In 2023, the AI in Genetics Market was valued at $35835.13 Million, and is projected to reach a market size of $112,536.54 Million by 2030. Over the forecast period of 2024-2030, market is projected to grow at a CAGR of 17.76%. The rising prevalence of epilepsy among the older population will be a prominent driver in the AI in genetics market.
Market Overview
Human genetics is the study of how genes are passed down through the generations. A little portion of a mutation caused by a change in the genome may lead to the illness phenotype. Different inheritance patterns, such as X-linked recessive, autosomal recessive, and autosomal dominant, are passed down from the parents to the children, and genetic illnesses can be monogenic, multifactorial, and chromosomal. The AI in the genetics market is likely to benefit from the increased use of genetic data in healthcare and technical advancements in genetic testing.
The increased focus of governments throughout the world on regulating and raising knowledge about genetic tests has resulted in a speedier acceptance of these tests around the world. Increased R&D expenditure, along with a strong market presence by established businesses, has created a high barrier to entry for new entrants. To maintain a competitive edge in the market, product design innovation, quality improvement, and strong distribution relationships are critical. Ricoh Company Ltd. and DNA Chip Research Inc., for example, launched RICOH Standard DNA Series EGFR mutation Type001, a reference DNA plate to be used in blood-based genetic testing in the diagnosis of lung cancer, in August 2021.
In nations such as the United States, China, and Japan, the use of direct-to-consumer genetic testing kits is fast increasing. The market for DTC-GT (Direct-to-Consumer Genetic Testing) kits is expected to grow significantly during the projected period, thanks to rising technological usage, more awareness initiatives, and lower pricing. Furthermore, underdeveloped countries such as India and other developing countries are likely to provide a profitable opportunity for firms seeking to establish a foothold in the genetic testing industry.
Covid-19 Impact on AI in Genetics Market
The COVID-19 pandemic has impacted the lives of many people all around the world. To combat the spread of the Coronavirus, government agencies have been obliged to institute lockdown and social separation policies. However, the pandemic has benefited the healthcare and life sciences industries substantially. Companies are rapidly producing solutions that aid in the microscopic study of human genetics, and artificial intelligence technologies are increasingly being employed for this purpose. Pharmaceutical companies can also develop personalized treatments for patients using genomics. Healthcare institutions, on the other hand, can use the notion of genetics to analyze an individual's genetic composition and develop a relevant diagnostic and therapeutic model, especially with advances in machine learning Furthermore, public health organizations are increasingly focusing on disease detection and prevention. Researchers are concentrating their efforts on using artificial intelligence approaches to learn more about the COVID-19 genomic sequences. For example, the sequential pattern mining (SPM) technique is used to analyze patterns in a corpus of COVID-19 genomic sequences that can be comprehended by a computer. As a result, the pandemic crisis has hastened the implementation of artificial intelligence in genetics, particularly for understanding patient genetic composition and the COVID-19 virus. As a result, in the future years, the pandemic is predicted to have a favorable impact on the global artificial intelligence (AI) in the genetics industry.
MARKET DRIVERS
Genetic testing is becoming more popular which is driving the market growth.
A genetic test is a form of medical examination that examines genes, chromosomes, or proteins for mutations. To conduct genetic tests, a sample of blood, hair, skin, amniotic fluid, or other tissue is needed. The sample is sent to a laboratory, where technicians look for specific abnormalities in chromosomes, DNA, or proteins, depending on the suspected condition. If necessary, the laboratory provides test findings to a doctor or the patient directly. Predictive and pre-symptomatic testing, carrier testing, prenatal and neonatal testing, diagnostic testing, pharmacogenomic testing, and other genetic tests can help establish whether a person has a genetic condition or is at risk of developing one.
Genetic data is becoming more widely used in healthcare, and genetic testing is becoming more advanced propelling the market growth
Noninvasive Prenatal Testing (NIPT), carrier testing, pharmacogenomic testing, karyotype testing, thrombophilia testing, predictive testing, ancestry & relationship testing, and other tests are examples of genetic testing. These examinations are gaining popularity in Spain. Data from these tests are being utilized to examine the history of diseases to make an informed conclusion. Furthermore, tailored data obtained from genetic testing assists consumers in becoming more proactive about their health, creating a profitable market opportunity.
MARKET RESTRAINTS
The market's expansion is being hampered by the high cost of genetic testing.
The cost of a genetic test typically ranges from $100 to $2,000, depending on the complexity of the test. More than one test is necessary to obtain the desired result, resulting in a cost increase. Despite breakthroughs in genetic testing, the cost has not decreased significantly. Furthermore, most insurance plans do not reimburse or only partially reimburse consumers for genetic tests, leading to a rising aversion to these tests among consumers. As a result, the industry is expected to be hampered by the high cost of genetic testing combined with a lack of insurance coverage.
The market's expansion is being hindered by a lack of competent AI workers and imprecise legal requirements.
Companies need a workforce with certain skill sets to design, manage and implement AI systems because AI is a complicated system. Personnel working with AI systems, for example, should be familiar with cognitive computing, machine learning, deep learning, and image recognition. Integrating AI into existing systems is also a difficult endeavor that necessitates substantial data processing to mimic human brain behavior. Even a little inaccuracy can cause system failure or harm the desired outcome.
AI IN GENETICS MARKET REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2023 - 2030 |
|
Base Year |
2023 |
|
Forecast Period |
2024 - 2030 |
|
CAGR |
17.76% |
|
By Application, Function, End-user, and Region |
|
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regional Scope |
North America, Europe, APAC, Latin America, Middle East & Africa |
|
Key Companies Profiled |
NIMGenetics (Spain), Sistemas Genómicos (Spain), FullGenomics (Spain), GENinCode (UK), Atrys Health (Spain), Geneva (Spain), Igenomix (India), Genologica (Spain), Bode Technology Group Inc (US) |
Wellness & E-Commerce
Preventive Medicine
Diagnostic & Treatment
Based on application, the market is segmented by Wellness & E-Commerce, Preventive Medicine, Diagnostic & Treatment. In this era of customization, where consumers may customize every part of their lives, health and wellness have gained a lot of traction in the consumer consciousness. The expanding consumer trend away from the traditional one-size-fits-all approach to health, nutrition, and wellbeing is assisting segment expansion by increasing demand for incorporating personalization into medical, nutrition, and wellness services. Because consumers are becoming more aware of genetic testing, healthcare is transitioning from treatment to prevention.
Doctors can use genetic testing to determine underlying genetic problems, which helps them provide better diagnostics and therapy. Segment acceptance has been enabled by technological breakthroughs in assessing genetic diseases, as well as increased consumer knowledge and comprehension of human genetics.
Genome Sequencing
Gene Editing
Predictive Testing Of Genes
Others
The global artificial intelligence (AI) in the genetics market is divided into three categories based on functions: genome sequencing, gene editing, and predictive gene testing, among others. Gene editing, also known as genome editing, is a collection of technologies that allow scientists to alter the DNA of living organisms. To create new genetic traits, materials can be added, changed, or removed from a piece of DNA. The introduction of CRISPR-Cas9 technology, which is reported to be cheaper, more accurate, and more effective than existing gene-editing approaches, is one of the most recent advancements in the field of gene editing. The breakthrough in gene editing using CRISPR-Cas9 is predicted to correct genetic abnormalities and diseases in the future years. Furthermore, the use of AI is likely to improve the accuracy and safety of CRISPR technology. The Wellcome Sanger Institute, for example, has created a machine learning-based system to improve the efficiency of CRISPR Cas9 gene editing by predicting errors in advance. forecast (preferred outcomes of repair events at Cas9 targets) is a program that can predict the outcome of gene repair using CRISPR Cas9, regardless of whether the operations are insertions or deletions. In the global artificial intelligence (AI) in genetics market in 2021, gene editing had the greatest market share.
Pharmaceutical & Biotech Companies
Healthcare Providers
Research Centers
Academic Institutes
Government Organizations
Other End Users
The market is divided into Pharmaceutical and Biotech Companies, Healthcare Providers, Research Centers, Academic Institutes, Government Organizations, and Other End Users, depending on the end-user. Pharmaceutical and biotechnology firms dominated the Global Artificial Intelligence in Genomics Market in 2021. Data is an important aspect of drug research for pharmaceutical companies since it provides evidence of safety and efficacy. As a result, AI assists in the efficient and secure analysis of this data.
The rising demand to reduce the time and costs of drug development, as well as the rising prevalence of diseases like cancer and genetic disorders, are likely to support this segment's growth.
North America
Asia Pacific
Latin America
Europe
Middle East and Africa
North America has the largest share of the global artificial intelligence (AI) in the genetics market by geography. North America's greater share of the global artificial intelligence (AI) in the genomics market is due to a higher concentration on research and development in nations like the United States and Canada, as well as the existence of key end-users, particularly in the pharmaceutical sector. Furthermore, public entities are spending large sums of money on genetics research, and artificial intelligence is being hailed as a tool that will elevate genetics, particularly in the area of gene prediction testing. The United States has been at the forefront of precision medicine, having been the first to sequence the human genome in the year 2000. . The number of start-ups offering AI-based genomics solutions is increasing in both the United States and Canada. DEEP GENOMICS, for example, is a Canadian firm that uses artificial intelligence to program RNA therapeutics for any gene or genetic problem. The AI-powered RNA workbench from DEEP GENOMIC aids in the untangling of RNA complications and gives an algorithm that can predict the best potential conclusion from hundreds of alternative outcomes, which is extremely time-consuming for humans.
The APAC region is predicted to develop the fastest in the global artificial intelligence (AI) in the genetics market over the forecast years, owing to the contributions of nations such as India, China, Japan, and Singapore. China's government invested roughly $9 billion as part of a 15-year goal to position the country as a leader in the use of artificial intelligence technologies to tackle the complexity of genetics. The country is collaborating with corporations, mostly in the United States, to gain access to a patient's genetic data to develop machine learning algorithms that can predict the best feasible treatment and diagnostic procedure based on their genetic makeup. The next gold rush in the field of healthcare is predicted to be machine learning models for cancer treatment using genomics. For example, Guangdong-based iCarbonX employs machine learning models to aid research in the life sciences. These elements are assisting the Asia-Pacific region in its ascension.
AI in Genetics Market by Company
Artificial intelligence is a highly competitive market in the Life Sciences industry, with several prominent competitors. It appears that the market is moderately concentrated. The market's leading players are concentrating their efforts on increasing their consumer base to include other countries. These businesses are making use of strategic collaboration initiatives to grow their market share and profits. To boost their product capabilities, market players are also purchasing start-ups focusing on artificial intelligence in life sciences technologies.
June 2020 - The University of Kentucky announced research cooperation with Atomwise, an industry leader in small chemical discovery utilizing artificial intelligence (AI), to investigate possible COVID-19 therapeutics. Some of the major players in the global human genetics market include
NIMGenetics (Spain)
Sistemas Genómicos (Spain)
FullGenomics (Spain)
GENinCode (UK)
Atrys Health (Spain)
Geneva (Spain)
Igenomix (India)
Genologica (Spain)
Bode Technology Group Inc (US)
NOTABLE HAPPENINGS IN THE AI IN GENETICS MARKET MARKET IN THE RECENT PAST:
Product Launch
In Oct 2021, Igenomix launched NACE, a non-invasive prenatal genetic screening test. Its purpose is to discover chromosomal abnormalities. This will assist the organization in revolutionizing the Indian market and expanding its market.
Partnerships and Collaborations
In June 2021, GENinCode announced a relationship with Eversana as its launch and commercialization partner, which would assist the GENinCode portfolio of polygenic cardiovascular disease treatments, which are primarily focused on hereditary risk, gain access to the US market.
In Jan 2021, Myriad Genetics and Illumina formed a strategic agreement in the field of oncology. A time-limited exclusive agreement for Illumina to produce a kit-based version of the myChoice CDx test for overseas markets is part of the strategic partnership between Myriad and Illumina.
Global automotive lighting refers to all vehicle lighting systems, from headlamps that illuminate the road to taillights that communicate movements. They guarantee motorists and other road users alike safety, visibility, and style. While taillights frequently use LEDs for improved visibility, headlights are available in a variety of technologies, including LED and laser. Interior illumination, DRLs, and signal lights all have a role to play. This market, which was estimated to be worth $33.64 billion in 2022, is anticipated to rise to $67.39 billion by 2030 because of laws, luxury tastes, safety concerns, and technological developments like OLED taillights and adaptive headlights. Anticipate a future dominated by intelligent, connected, personalized, and sustainable lighting systems that enhance the safety, efficiency, and aesthetic appeal of automobiles.
Car lighting works its magic to provide safety, visibility, and style. Headlights cut through the night, taillights express intent, and interiors shine with comfort. The billion-dollar global business is expected to rise due to consumer demand for high-end experiences, safer roads, and cutting-edge technology. Imagine dynamic messages being painted by taillights, headlights that adjust to the road, and interiors that customize their atmosphere. Driven by technological advancements like linked systems and laser beams, this future is calling. Anticipate even more visually attractive, environmentally friendly, and intelligent lighting to illuminate the way ahead, making cars safer, more efficient, and unquestionably cooler.
In the market for automobile lighting, safety is the driving force behind demand from the public and laws. While automated high beams smoothly react to traffic, adaptive headlights modify their beams so as not to blind other people. With visually striking displays, dynamic taillights convey intentions for braking and turning. Beyond these developments, integrated pedestrian identification and lane departure alerts will soon make roads safer and brighter for everyone.
Luxurious automobile lighting creates a distinct visual identity that goes beyond simple illumination. Personalized interior lighting customizes the driving experience by setting the mood with a range of colours and intensities, while intricate designs and distinctive DRLs modify exteriors. As you approach your automobile at night, welcoming lights lead the way, resulting in an interior that is perfectly lit. Not only is this symphony of light aesthetically pleasing, but it also stands as a tribute to luxury. Upcoming developments like gesture-controlled lighting and holographic displays promise to further enhance the experience.
The worldwide automotive lighting market is undergoing a significant transition towards energy-efficient solutions, as environmental concerns gain prominence. LED technology is leading the way, providing a ray of hope for the environment and drivers alike. LED lights beam brighter and use a lot less energy than conventional halogen lamps. There are some tangible advantages to this. For drivers, this translates to increased fuel economy, which lowers petrol prices and lessens reliance on fossil fuels. Greater air quality and a reduction in the transport sector's contribution to climate change are the results of reduced overall emissions.
Although the global automotive lighting business is booming, there are still unknowns. Difficulties impede growth even as innovation propels it with eye catching features like laser beams and adaptable headlights. These technologies are luxury items due to their high cost and difficult integration, which puts producers' abilities to the test. The worldwide patchwork created by unclear legislation limits the potential of innovation. Durability issues persist, particularly when complex systems are subjected to challenging conditions. Ultimately, a lot of drivers still don't fully understand how these improvements can help them. Together, we can overcome these obstacles. The keys to reducing costs are improved production, more seamless integration, and unified regulations. Their full potential can be realized by educating customers about the safety, efficiency, and aesthetic value of these lighting wonders. By working together, we can pave the way for an even brighter and safer future for vehicle lighting.
It is made possible by advanced LED technology, which gives drivers the ability to customize their illumination for the highest level of comfort and flair. Consumers that care about the environment want greener products, and vehicle lighting complies. While solar- and self-powered lighting technologies offer a future powered by clean energy, energy-efficient LEDs lower pollution. The advent of connected lighting systems heralds a new age. Envision automobiles interacting with infrastructure and one another to minimize accidents and enhance traffic efficiency. Integrated headlights with pedestrian recognition provide unmatched safety, while dramatic taillights with eye-catching displays alert onlookers to your intentions. The possibilities are endless in the future. Gesture-controlled interior illumination, holographic displays projected onto the road, and even light fixtures with self-healing capabilities.
Due to laws requiring safety features like headlights, taillights, and brake lights, exterior lighting presently holds the most market share in the vehicle lighting industry. The dominance of this market is partly attributed to advancements in safety-focused technologies such as adaptive headlights and daytime running lights. The market value of external lighting is increased by the quick adoption of technology like LED bulbs and laser lights, which improve performance and aesthetics. Conversely, the interior lighting market is expected to increase at the fastest rate in the upcoming years. Innovations like ambient lighting and technology breakthroughs like LED and OLED displays, driven by consumer demand for comfort and personalisation, open new possibilities. The spread of sophisticated interior lighting systems is further driven by the growing emphasis on safety and the expansion of the luxury car market.
The worldwide vehicle lighting market is currently dominated by halogen because of its more affordable price, advanced technology, and useful illumination. With its dependable supply chain and affordable option for manufacturers and cost-conscious customers, halogen holds the biggest market share. The fastest-growing market right now is LEDs, which are predicted to shortly overtake halogen. The rapid expansion of LEDs is driven by their higher efficiency, longer lifespan, flexibility in design, and technological breakthroughs including enhanced brightness. Because LEDs use less energy and produce fewer emissions and better fuel economy, they are becoming more and more popular in the changing automotive lighting market.
Passenger automobiles rule the worldwide automotive lighting market. The sheer number of passenger cars produced which surpasses that of business vehicles and fuels the need for lighting systems is the primary cause of this popularity. The growing demand for personal automobiles in developing nations is a result of rising disposable income, which in turn drives the rise of the passenger car market. The importance that consumers place on safety and aesthetics elements helps to drive market expansion. But in the upcoming years, the market for electric and hybrid cars is expected to develop at the quickest rate. The exponential rise of the worldwide electric car market, which is still expanding and shows no signs of slowing down, is what is driving this surge. Specialised lighting solutions are required since electric and hybrid vehicles have different lighting requirements because of their specific functionality and design aesthetics.
Most lighting systems sold nowadays are sold by OEMs (Original Equipment Manufacturers), primarily because manufacturers pre-install lighting systems in new cars. But in the next years, the aftermarket is expected to develop at the quickest rate. This spike in demand for replacement parts, especially lighting systems, can be linked to several variables, one of them being the average age of cars. The industry is expanding because of consumers' growing desire to personalise their cars with aftermarket lighting upgrades such LED upgrades and decorative lighting. The availability and affordability of technologies like adaptive headlights and laser lights in the aftermarket, together with other advancements in lighting technology, are driving demand even more. Moreover, the growing market for electric cars (EVs).
Throughout the forecast period, Asia Pacific is anticipated to be the automotive lighting market with the highest profitability. Over the past few years, Asia Pacific countries like China and India have seen notable increases in automotive manufacturing and sales, primarily in the medium-to premium luxury car segment. Asia Pacific is predicted to see an increase in the manufacturing of passenger cars, with India experiencing the strongest growth rate. Depending on the state of the national economy, the area offers a suitable selection of both high-end and cheap cars. For instance, there is a substantial demand for halogen, Xenon/HID, and LED since China and India produce more economy and mid-range automobiles. On the other hand, luxury car adoption rates are greater in South Korea and Japan, where LED lighting is the norm.
A brief shadow was thrown by COVID-19 over the worldwide automotive lighting market. Production was stopped by lockdowns and supply chain disruptions, while luxury lighting upgrades were shelved by consumers on a tight budget. Resources became scarce, and R&D stagnated. Still, the market is recovering thanks to resurgent demand and rearranged priorities. While energy-efficient LEDs are being pushed towards adoption by sustainability, safety concerns are driving interest in features like pedestrian detection and adaptive headlights. The digital push of the epidemic creates opportunities for intelligent, networked lighting systems that may interact with infrastructure and other cars. Ultimately, the industry is positioned to shine brighter, focused on safety, sustainability, and a connected future, even though the pandemic dimmed its brilliance.
A development collaboration between OSRAM Continental and REHAU aims to incorporate lighting into external components, providing automobile manufacturers with innovative lighting options that improve functionality and design flexibility. For rear combination lamps, Hella unveiled a revolutionary lighting innovation called Hella FlatLight technology. A Memorandum of Understanding (MoU) was signed by Samvardhana Motherson Automotive Systems Group BV (SMRPBV), a division of Motherson Group, and Marelli Automotive Lighting to investigate a technology collaboration focused on intelligently lighted external body components. Valeo debuted their revolutionary 360° lighting system at the Shanghai Auto Show. This technology surrounds the car with a band of light, projecting instantaneous, clear signs that other drivers can see from a distance. Pedestrians, cyclists, and scooter riders are especially susceptible to these signals
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
Specify your preferred Countries, Segments, or timeframes
Unlock Country Level Outlook, Trends, Cross-country Comparability, or supply Chain Variations.
Analyst Support
Every order comes with Analyst Support.
Customization
We offer customization to cater your needs to fullest.
Verified Analysis
We value integrity, quality and authenticity the most.
